Data monitoring committees

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/EWP/5872/03
Effective from01/01/2006
KeywordsSafety monitoring, benefit/risk assessment, interim analysis, futility, type 1 error control, study integrity, study conduct
DescriptionThis document deals with independent data monitoring committees. It highlights the key issues involved when sponsors include data monitoring committees as a part of their trial management.

Related content


How helpful is this page?

Average rating:

 Based on 31 ratings

Add your rating:

See all ratings
6 ratings
7 ratings
6 ratings
6 ratings
6 ratings

Tell us more